Phospholipid asymmetry in health and disease

Current Opinion in Hematology

Volumn 5, Issue 2, 1998, Pages 122-131

  Kuypers, Frans A ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLSERINE;

DIABETES MELLITUS; GENERAL ASPECTS OF DISEASE; HEMOSTASIS; LIPID BILAYER; MACROPHAGE; MEMBRANE STRUCTURE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA;

EID: 0031948732     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199803000-00007     Document Type: Review

References (107)

1. Bretcher M: Phosphatidylethanolamine: Differential labeling in intact cells and cell ghosts of human erythrocytes by a membrane impermeable reagent. J Mol Biol 1972, 71:523-528.
2. Bretcher M: Asymmetrical lipid bilayer structure for biological membranes. Nature 1972, 236:11-12.
3. Roelofsen B: Phospholipases as tools to study the localization of phospholipids in biological membranes: A critical review. J Toxicol 1982, 1:87-197.
4. Op den Kamp JAF: Lipid asymmetry in membranes. Ann Rev Biochem 1979, 48:47-71.
5. Seigneuret M, Devaux PF: ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci U S A 1984, 81:3751-3755.
6. Devaux PF, Zachowski A, Favre E, Fellmann P, Cribier S, Geldwerth D, Herve P, Seigneuret M: Energy-dependent translocation of aminophospholipids in the erythrocyte membrane. Biochimie 1986, 68:383-393.
7. Daleke DL, Huestis WH: Incorporation and translocation of aminophospholipids in human erythrocytes. Biochemistry 1985, 24:5406-5416.
8. Devaux PF, Zachowski A: Maintenance and consequences of membrane phospholipid asymmetry. Chem Phys Lipids 1994, 73:107-120.
9. Diaz C, Schroit AJ: Role of translocases in the generation of phosphatidylserine asymmetry. J Membr Biol 1996, 151:1-9.
10. Bitbol M, Devaux PF: Measurement of outward translocation of phospholipids across human erythrocyte membrane. Proc Natl Acad Sci U S A 1988, 85:6783-6787.
11. Connor J, Pak CH, Zwaal RF, Schroit AJ: Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process. J Biol Chem 1992, 267:19412-19417.
12. Williamson P, Bevers EM, Smeets EF, Comfurius P, Schlegel RA, Zwaal RF: Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 1995, 34:10448-10455.
13. Basse F, Stout JG, Sims PJ, Wiedmer T: Isolation of an erythrocyte membrane protein that mediates Ca2+-dependent transbilayer movement of phospholipid. J Biol Chem 1996, 271:17205-17210.
14. Zhou QS, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ: Molecular cloning of human plasma membrane phospholipid scramblase: A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem 1997, 272:18240-18244. This paper is the first to identify the sequence of the scramblase, a keyplayer in the loss of phospholipid asymmetry in human erthryoctyes.
15. Myher JJ, Kuksis A, Pind S: Molecular species of glycerophospholipids and sphingomyelins of human erythrocytes: Improved method of analysis. LIPIDS 1989, 24:396-407.
16. Kuypers FA, Abraham S, Lubin B, Chiu D: Diet-induced asymmetry of the phosphatidylcholine fatty acyl composition in rat erythrocyte membranes. J Lab Clin Med 1988, 111:529-536. [published erratum appears in J Lab Clin Med 1988 Sep; 112(3):282]
17. Zwaal R, Bevers E, Rosing J: Phospholipids in the clotting process. In Phospholipid-Binding Antibodies. Edited by Nigel Harris E, Exner T, Hughes G, Asherson R: Boston: CRC Press; 1991:31-59.
18. Zwaal RF, Comfurius P, Bevers EM: Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes. Biochem Soc Trans 1993, 21:248-253.
19. Comfurius P, Bevers E, Zwaal RF: Prothrombinase complex as a tool to assess changes in membrane phospholipid asymmetry. Methods Mol Biol 1994, 27:131-142.
20. Raynal P, Pollard HB: Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochimica Biophysica Acta 1994, 1197:63-93.
21. Dachary-Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT: Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 1993, 81:2554-2565.
22. Koopman G, Reulelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cytemetric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420.
23. Kuypers FA, Lewis RA, Ernst JD, Discher D, Lubin BH: Detection of altered membrane phospholipid asymmetry in subpopulations of human red cells using fluorescently labeled annexin V. Blood 1996, 87:1179-1187.
24. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995, 184:39-51.
25. Kuypers FA, van den Berg JJM, Lubin BH: Phospholipid asymmetry and diffusion in the membrane of normal and sickle erythrocytes. In Membrane Abnormalities in Sickle Cell Disease and in Other Red Blood Cell Disorders. Edited by Ohnishi, ST, Ohnishi, S. Boca Raton, FL: CRC Press; 1993:21-55.
26. Zwaal RF, Schroit AJ: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997, 89:1121-1132.
27. Roelofsen B: Molecular architecture and dynamics of the plasma membrane lipid bilayer: the red blood cell as a model. Infection 1991, 19:S206-209.
28. Devaux PF: Protein involvement in transmembrane lipid asymmetry. Annu Rev Biophys Biomol Struct 1992, 21:417-439.
29. Schroit AJ, Zwaal RF: Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1991, 1071:313-329.
30. Connor J, Schroit AJ: Determination of lipid asymmetry in human red cells by resonance energy transfer. Biochemistry 1987, 26:5099-5105.
31. Sune A, Bette-Bobillo P, Bienvenue A, Fellmann P, Devaux PF: Selective outside-inside translocation of aminophospholipids in human platelets. Biochemistry 1987, 26:2972-2978.
32. Tilly RH, Senden JM, Comfurius P, Bevers EM, Zwaal RF: Increased aminophospholipid translocase activity in human platelets during secretion. Biochim Biophys Acta 1990, 1029:188-190.
33. Julien M, Tournier JF, Tocanne JF: Basic fibroblast growth factor modulates the aminophospholipid translocase activity present in the plasma membrane of bovine aortic endothelial cells. Eur J Biochem 1995, 230:287-297.
34. Muller K, Labbe C, Zachowski A: Phospholipid transverse asymmetry in trout spermatozoa plasma membrane. Biochim Biophys Acta 1994, 1192:21-26.
35. Muller K, Pomorski T, Marienfeld K, Herrmann A, Muller P: Transverse mobility of aminophospholipids in the plasma membrane of ram sperm cells. Pflugers Arch 1996, 431:R255-256.
36. Herrmann A, Zachowski A, Devaux PF: Protein-mediated Phospholipid translocation in the endoplasmic reticulum with a low lipid specificity. Biochemistry 1990, 29:2023-2027.
37. Zachowski A, Henry JP, Devaux PF: Control of transmembrane lipid asymmetry in chromaffin granules by an ATP-dependent protein. Nature 1989, 340:75-76.
38. Morrot G, Herve P, Zachowski A, Fellmann P, Devaux PF: Aminophospholipid translocase of human erythrocytes: Phospholipid substrate specificity and effect of cholesterol. Biochemistry 1989, 28:3456-3462.
39. Beleznay Z, Zachowski A, Devaux PF, Navazo MP, Ott P: ATP-dependent aminophospholipid translocation in erythrocyte vesicles: Stoichiometry of transport. Biochemistry 1993, 32:3146-3152.
40. Beleznay Z, Zachowski A, Devaux PF, Ott P: Characterization of the correlation between ATP-dependent aminophospholipid translocation and Mg2+-ATPase activity in red blood cell membranes. Eur J Biochem 1997, 243:58-65.
41. Geldwerth D, Kuypers FA, Bütikofer P, Allary M, Lubin BH, Devaux PF: Transbilayer mobility and distribution of red cell phospholipids during storage. J Clin Invest 1993, 92:308-314.
42. de Jong K, Geldwerth D, Kuypers FA: Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes. Biochemistry 1997, 36:6768-6776. Oxidant-induced damage has been proposed to be the underlying mechanism for loss of membrane phospholipid asymmetry. This paper reports that erythrocytes did not expose PS as the result of a variety of oxidative insult, despite damage and impairment of flipase activity. The results indicate that oxidant damage does not induce exposure of phosphatidylserine on the membrane surface, but can interfere with both aminophosphilipid translocase activity or calcium-induced randomization of membrane phospholipids.
43. Connor J, Schroit AJ: Transbilayer movement of phosphatidylserine in erythrocytes: Inhibition of transport and preferential labeling of a 31,000-dalton protein by sulfhydryl reactive reagents. Biochemistry 1988, 27:848-851.
44. Bitbol M, Fellmann P, Zachowski A, Devaux PF: Ion regulation of phosphatidylserine and phosphatidylethanolamine outside translocation in human erythrocytes. Biochim Biophys Acta 1987, 904:268-282.
45. Tilley L, Cribier S, Roelofsen B, Op den Kamp JA, van Deenen LL: ATP-dependent translocation of amino phospholipids across the human erythrocyte membrane. FEBS Lett 1986, 194:21-27.
46. Morrot G, Zachowski A, Devaux PF: Partial purification and characterization of the human erythrocyte Mg2(+)-ATPase. A candidate aminophospholipid translocase. FEBS Lett 1990, 266:29-32.
47. Zimmerman ML, Daleke DL: Regulation of a candidate aminophospholipid-transporting ATPase by lipid. Biochemistry 1993, 32:12257-12263.
48. Auland ME, Roufogalis BD, Devaux PF, Zachowski A: Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes. Proc Natl Acad Sci U S A 1994, 91:10938-10942.
49. Tang X, Halleck MS, Schlegel RA, Williamson P: A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 1996, 272:1495-1497. This paper reports the cloning and sequencing of a member of subfamily of P-type ATPases with aminophosolipid transporting activity. The protein was not reported to be brought to expression to directly proof its ability to transport PS across a bilayer, but studies in Saccharomyces cerevisiae suggest that aminophospholipid translocation is a general function of members of this protein family.
50. Zhao J, Sims PJ, Wiedmer T: Production and characterization of a mutant cell line defective in aminophospholipid translocase. Biochim Biophys Acta 1997, 1357:57-64. The identification of cell lines that have a decreased flipase activity as reported in this paper, will be powerful tools, suitable for expression cloning of cDNAs coding for candidate flipases. Similar approaches will be important to characterize other proteins involved in maintenance of membrane phospholipid organization.
51. Andrick C, Broring K, Deuticke B, Haest CW: Fast translocation of phosphatidylcholine to the outer membrane leaflet after its synthesis at the inner membrane surface in human erythrocytes. Biochim Biophys Acta 1991, 1064:235-241.
52. Bevers EM, Comfurius P, Zwaal RF: Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983, 736:57-66.
53. Williamson P, Kulick A, Zachowski A, Schlegel RA, Devaux PF: Ca2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry 1992, 31:6355-6360.
54. Dressler V, Haest CW, Plasa G, Deuticke B, Erusalimsky JD: Stabilizing factors of phospholipid asymmetry in the erythrocyte membrane. Biochim Biophys Acta 1984, 775:189-196.
55. Franck PF, Bevers EM, Lubin BH, Comfurius P, Chiu DT, Op den Kamp JA, Zwaal RF, van Deenen LL, Roelofsen B: Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J Clin Invest 1985, 75:183-190.
56. de Jong K, Beleznay Z, Ott P: Phospholipid asymmetry in red blood cells and spectrin-free vesicles during prolonged storage. Biochim Biophys Acta 1996, 1281:101-110.
57. de Jong K, Ott P: Membrane phospholipid asymmetry in DMPC-induced human red cell vesicles. FEBS Lett 1993, 334:183-188.
58. Kuypers FA, Lubin BH, Yee M, Agre P, Devaux PF, Geldwerth D: The distribution of erythrocyte phospholipids in hereditary spherocytosis demonstrates a minimal role for erythrocyte spectrin on phospholipid diffusion and asymmetry. Blood 1993, 81:1051-1057.
59. Van der Meer BW, Fugate RD, Sims PJ: Complement proteins C5b-9 induce transbilayer migration of membrane phospholipids. Biophys J 1989, 56:935-946.
60. Fattal E, Nir S, Parente RA, Szoka FC, Jr: Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry 1994, 33:6721-6731.
61. Hamilton KK, Hattori R, Esmon CT, Sims PJ: Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990, 265:3809-3814.
62. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ: Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988, 263:18205-18212.
63. Sulpice JC, Zachowski A, Devaux PF, Giraud F: Requirement for phosphatidylinositol 4,5-bisphosphate in the Ca2+-induced phospholipid redistribution in the human erythrocyte membrane. J Biol Chem 1994, 269:6347-6354.
64. Bevers EM, Wiedmer T, Comfurius P, Zhao J, Smeets EF, Schlegel RA, Schroit AJ, Weiss HJ, Williamson P, Zwaal RFA, Sims PJ: The complex of phosphatidylinositol 4,5-bisphosphate and calicum ions is not responsible for Ca2+-induced loss of phospholipid asymmetry in the human erythrocyte: A study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling. Blood 1995, 86:1983-1991.
65. Sulpice JC, Moreau C, Devaux PF, Zachowski A, Giraud F: Antagonist effects of Ca2+ and spermine on phosphatidylinositol 4,5-bisphosphate-mediated transmembrane redistribution of phospholipids in large unilamellar vesicles and in erythrocytes. Biochemistry 1996, 35:13345-13352.
66. Shifter K, Rood L, Emmerson R, Kuypers FA: The effects of phosphatidylinositol diphosphate (PIP2) on the human erythrocyte membrane. Biochemistry 1998, in press.
67. Li Q, Jungmann V, Kiyatkin A, Low PS: Prostaglandin E2 stimulates a Ca2+-dependent K+ channel in human erythrocytes and alters cell volume and filterability. J Biol Chem 1996, 271:18651-18656.
68. Mold C: Effect of membrane phospholipids on activation of the alternative complement pathway. J Immunol 1989, 143:1663-1668.
69. Wang RH, Phillips G, Jr, Medof ME, Mold C: Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest 1993, 92:1326-1335.
70. Test ST, Mitsuyoshi J: Activation of the alternative pathway of complement by calcium-loaded erythrocytes resulting from loss of membrane phospholipid asymmetry. J Lab Clin Med 1997, 130:169-182. The importance of PS exposure is well established in regulatory mechanisms of hemostasis. This study demonstrates that loss of phospholipid asymmetry in erythrocytes not only results in expression of procoagulant activity but also renders the cells capable of affecting the alternative pathway of complement.
71. Tanaka Y, Schroit A: Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells: Recognition by autologous macrophages. J Biol Chem 1983, 258:11335-11343.
72. Schroit AJ, Madsen JW, Tanaka Y: In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 1985, 260:5131-5138.
73. Connor J, Pak CC, Schroit AJ: Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994, 269:2399-2404.
74. Gaffet P, Basse F, Bienvenue A: Loss of phospholipid asymmetry in human platelet plasma membrane after 1-12 days of storage. An ESR study. Eur J Biochem 1994, 222:1033-1040.
75. Herrmann A, Devaux PF: Alteration of the aminophospholipid translocase activity during in vivo and artificial aging of human erythrocytes. Biochim Biophys Acta 1990, 1027:41-46.
76. Jain SK: Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 1988, 937:205-210.
77. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, Van Schie R, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995, 182:1545-1556.
78. Fadok VA, Voelker DR, Campbell PA, Bratton DL, Cohen JJ, Noble PW, Riches DW, Henson PM: The ability to recognize phosphatidylserine on apoptotic cells is an inducible function in murine bone marrow-derived macrophages. Chest 1993, 103:
79. McConkey DJ, Orrenius S: The role of calcium in the regulation of apoptosis. J Leukoc Biol 1996, 59:775-783.
80. Vito P, Lacana E, D'Adamio L: Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996, 271:521-525.
81. Conroy LA, Jenkinson EJ, Owen JJ, Michell RH: Phosphatidylinositol 4,5-bisphosphate hydrolysis accompanies T cell receptor-induced apoptosis of murine thymocytes within the thymus. Eur J Immunol 1995, 25:1828-1835.
82. Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, Henson PM: Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997, 272:26159-26165. In the last few years, it has become apparent that PS exposure is an important early step in apoptosis. This paper describes aspects of the underlying mechanisms that determine this loss of phospholipid asymmetry, and identifies calcium as a key factor.
83. Mower DA, Jr, Peckham DW, Illera VA, Fishbaugh JK, Stunz LL, Ashman RF: Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J Immunol 1994, 152:4832-4842.
84. Rouby R: Autoantibodles to phospholipid-binding ptroteins: A new view of lupus anticoagulant and other "anti phospholipid" antibodies. Blood 1994, 84:2854-2867.
85. McKanna JA: Lipocortin 1 in apoptosis: Mammary regression. Anat Rec 1995, 242:1-10.
86. Nakamura N, Shidara Y, Kawaguchi N, Azuma C, Mitsuda N, Onishi S, Yamaji K, Wada Y: Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: Involvement of annexin V. Biochem Biophys Res Commun 1994, 205:1488-1493.
87. Nakamura N, Kuragaki C, Shidara Y, Yamaji K, Wada Y: Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties. Am J Hematol 1995, 49:347-348.
88. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D: The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 1995, 92:9580-9584.
89. Rigotti A, Acton SL, Krieger M: The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995, 270:16221-16224.
90. Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995, 181:1857-1862.
91. Fadok VA, Laszlo DJ, Noble PW, Weinstein L, Riches DW, Henson PM: Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J Immunol 1993, 151:4274-4285.
92. Bennett MR, Gibson DF, Schwartz SM, Tait JF: Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995, 77:1136-1142.
93. Tait JF, Gibson D: Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med 1994, 123:741-748.
94. de Jong K, van Rossum L, Lubin BH, Styles L, Kuypers FA: Phosphatidylserine externalization in subpopulations of sickle cells. Blood 1997, 90:125a.
95. Styles L, de Jong K, Vichinsky E, Lubin B, Adams R, Kuypers F: Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening. Blood 1997, 90:604a.
96. Blumenfeld N, Zachowski A, Galacteros F, Beuzard Y, Devaux P: Transmembrane mobility of phospholipids in sickle erythrocytes: Effect of deoxygenation on diffusion and asymmetry. Blood 1991, 77:849-854.
97. Yuan J, Angelucci E, Lucarelli G, Aljurf M, Snyder LM, Kiefer CR, Ma L, Schrier SL: Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia). Blood 1993, 82:374-377.
98. Yuan J, Kuypers FA, Lewis RA, Fucharoen S, Bunyaratvej A, Schrier SL: Membrane lipid asymmetry in thalassemic RBC. Blood 1994, 84:259a.
99. Yuan J, Rubin E, Paszty C, Schrier SL: Programmed cell death in the spleens of beta thalassemic mice. Blood 1995, 86:8a.
100. Kuypers FA, Yuan J, Lewis RA, Snyder LM, Kiefer CR, Bunyaratvej A, Fucharoen S, Ma L, Styles L, de Jong K, Schrier SL: Membrane phospholipid asymmetry in human thalassemia. Blood 1998, in press.
101. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A: Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotlc episodes. Am J Hematol 1993, 44:63-65.
102. Wilson MJ, Richter-Lowney K, Daleke DL: Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes. Biochemistry 1993, 32:11302-11310.
103. Lupu C, Calb M, Ionescu M, Lupu F: Enhanced prothrombin and intrinsic factor X activation on blood platelets from diabetic patients. Thromb Haemost 1993, 70:579-583.
104. Vermeulen WP, Briede JJ, Bunt G, Op den Kamp JA, Kraaijenhagen RJ, Roelofsen B: Enhanced Mg(2+)-ATPase activity in ghosts from HS erythrocytes and in normal ghosts stripped of membrane skeletal proteins may reflect enhanced aminophospholipid translocase activity. Br J Haematol 1995, 90:56-64.
105. Wood KA, Youle RJ: Apoptosis and free radicals. Ann NY Acad Sci 1994, 738:400-407.
106. Bevers EM, Wiedmer T, Comfurius P, Shattil SJ, Weiss HJ, Zwaal RF, Sims PJ: Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: A study of the red blood cells of Scott syndrome. Blood 1992, 79:380-388.
107. 3+ with the scramblase on the endofacial surface of the cell membrane.